Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

IBB vs IGIB: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, IBB returned +37.5% to IGIB's −1.8%, and IGIB charges 0.04% to IBB's 0.44%.

askIQ about this page

askIQ about IBB and IGIB

Net assets: $11.0bn on Oct 27, 2026 for iShares Biotechnology ETF, and $19.5bn on Oct 28, 2026 for iShares 5-10 Year Investment Grade Corporate Bond ETF.

At a glance
+37.5%
IBB total return, 1 year
−1.8%
IGIB total return, 1 year
0.44%
IBB expense ratio
0.04%
IGIB expense ratio

Pair scorecard

IGIB costs 0.40 points a year less; their one-year returns differ by 39.3 points; IGIB is 1.8 times larger.

IBB vs IGIB: Differences, Returns & Fees
MeasureIBBIGIB
Return
Total return, 1 year+37.5%−1.8%
Drawdown
Below its high3.2%, high on Feb 27, 2026
Benchmark
What it tracksBiotechICE BofA 5-10 Year US Corporate Index
Cost and size
Expense ratio0.44%0.04%
Net assets, as of Oct 26, 2026$10.7bn$19.5bn
Active share vs the S&P 50099%
Holdings
Holdings in common0%
In the S&P 500, by weight40%
Top ten holdings, share of the fund50%

Holdings in common uses holdings dated Oct 27, 2026. Method

Risk and return

Jan 19, 2007 to Oct 23, 2026 · 1,031 weekly returns
IBB IGIB
Return
Total return edge IBB +703.0% +104.0%
Annualized edge IBB +11.1% +3.7%
Price return edge IBB +668.6% +1.8%
Risk
Volatility edge IGIB 22.9% 6.0%
Max drawdown edge IGIB −37.5% −20.0%
Risk-adjusted
Sharpe edge IBB 0.50 0.37
Sortino edge IBB 0.72 0.49
Calmar edge IBB 0.30 0.18
Reading

IBB returned more: +703.0% to +104.0%. IGIB swung less: 6.0% to 22.9%. IGIB fell less at its worst: −20.0% to −37.5%.

Full scorecard

9 measures, with how each is measured
Open ↓
Risk and return: IBB vs IGIB: Differences, Returns & Fees
MeasureIBBIGIBEdgeHow it is measured
Return
Total return+703.0%+104.0%IBBPrice change plus distributions, reinvested.
Annualized+11.1%+3.7%IBBTotal return as a yearly rate.
Price return+668.6%+1.8%IBBPrice change alone, distributions left out.
Risk
Volatility22.9%6.0%IGIBSpread of weekly returns, annualized. Lower is steadier.
Downside deviation16.0%4.4%IGIBLike volatility, counting only weeks below the Treasury bill rate.
Max drawdown−37.5%−20.0%IGIBDeepest fall from a high to the low after it.
Risk-adjusted
Sharpe0.500.37IBBReturn above Treasury bills per unit of volatility.
Sortino0.720.49IBBReturn above Treasury bills per unit of downside deviation.
Calmar0.300.18IBBAnnualized return divided by the max drawdown.

Computed by ETFIQ from Tiingo daily prices and ETFIQ's distribution records, 1,031 weekly returns. Cash rate: the 13-week Treasury bill.

What they share

0%

By the books each fund has filed, IBB and IGIB hold 0% of their money in the same securities at the same weight. Holdings dated Oct 27, 2026.

0 half 100%

half

0% in common

Positions both hold · largest shared weight first IBB IGIB
Only in one fund ↓
Only in IBB
GILEAD SCIENCES 8.56%
AMGEN INC 8.20%
VERTEX PHARMACEUTICALS 7.53%
REGENERON PHARMACEUTICALS 5.64%
MODERNA 5.29%
NATERA 3.85%
ARGENX SE ADR 3.42%
ILLUMINA INC 2.93%
Only in IGIB
AMAZON.COM INC 0.22%
META PLATFORMS INC 0.22%
META PLATFORMS INC 0.20%
ANHEUSER-BUSCH COMPANIES LLC 0.19%
BANK OF AMERICA CORP MTN 0.19%
SPACE EXPLORATION TECHNOLOGIES COR 144A 0.19%
BANK OF AMERICA CORP MTN 0.18%
BANK OF AMERICA CORP MTN 0.18%
Check overlap with more funds →

Side by side

IBB iShares Biotechnology ETF IGIB iShares 5-10 Year Investment Grade Corporate Bond ETF
Where it sits Thematic ETF Bond ETF
What it is Biotech Tracks an index of 5-10 Year Investment Grade Corporate Bond
Total return, 1 year +37.5% −1.8%
Expense ratio 0.44% 0.04%
Holdings 245 3064
Net assets, IBB as of Oct 27, 2026 and IGIB as of Oct 28, 2026 $11.0bn $19.5bn

IBB and IGIB on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Client brief · page 1 of 2 Report BR-01668C260C

IBB and IGIB do different jobs. What does each one do in a portfolio?

  1. What each follows. IBB follows Biotech and IGIB follows ICE BofA 5-10 Year US Corporate Index.
  2. Holdings in common. 0% of the weight is in the same securities (holdings dated Oct 27, 2026).
  3. One-year total return. Over 1 year to Oct 28, 2026 IBB returned +37.5% and IGIB −1.8% with distributions reinvested, a gap of 39.3 points.

Data as of Oct 28, 2026.

The two-page PDF for this pair is coming. Save the comparison to follow its changes. Free. It needs an email sign-in, once.

Your saved page · Privacy.

Alert

IBB and IGIB flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
IBB

By weight, 40% of IBB's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 50% of the fund across 245 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +37.5% with distributions reinvested.

IGIB

IGIB tracks an index of 5-10 Year Investment Grade Corporate Bond. Over the year to Oct 28, 2026 it returned −1.8% with distributions reinvested. The prospectus expense ratio is 0.04% a year. It sat 3.2% below its high of Feb 27, 2026 on Oct 28, 2026.

Questions people ask

Are IBB and IGIB in the same category?
IBB is a thematic ETF and IGIB is a bond ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, IBB or IGIB?
In the year to Oct 28, 2026, with distributions reinvested, IBB returned +37.5% and IGIB −1.8%.
Which is cheaper, IBB or IGIB?
IGIB is cheaper, by 0.40 percentage points a year. That is about $40 on $10,000 held for a year. Fees come from each fund's prospectus.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, IBB against IGIB, data as of Oct 28, 2026. https://etfiq.com/compare/any/ibb-vs-igib

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.